Medtronic on Feb. 21 posted $7.7 billion in revenue during the third quarter of fiscal year 2023.
Five things to know:
1. Medtronic's revenue grew 4.1 percent year-over-year on an organic basis, according to a news release.
2. Cranial and spinal technologies raked in $1.1 billion, a 2.8 percent increase compared to the same time last year. Medtronic's spine biologics saw low growth, and the neurosurgery segment saw high-single digit growth.
3. The robotics, navigation, imaging and powered surgical instruments segment saw double-digit growth year-over-year.
4. Medtronic's cardiovascular portfolio brought in $2.8 billion, a 1 percent increase year-over-year.
5. The company increased its outlook for fiscal year 2023 and expects fourth quarter revenue growth of 4.5 percent to 5 percent.